Example Order Set for Alcohol Detoxification Using Lorazepam and CIWA-Ar
For adult patients at risk for alcohol withdrawal syndrome, implement a symptom-triggered lorazepam protocol guided by CIWA-Ar scores, administering lorazepam 2-4 mg PO/IV every hour when CIWA-Ar ≥8-10, with lorazepam being the preferred benzodiazepine in patients with hepatic dysfunction. 1, 2
Assessment and Monitoring Orders
- CIWA-Ar scoring every 1-2 hours until score remains <8-10 for 24 hours, then extend to every 4-6 hours 1, 2
- Assess for hepatic dysfunction (AST, ALT, bilirubin, INR) as lorazepam is safer than long-acting benzodiazepines in liver disease 1
- Monitor vital signs with each CIWA-Ar assessment (blood pressure, heart rate, temperature) 1
- Screen for seizure history and delirium tremens risk factors 1
Pharmacologic Treatment Orders
Symptom-Triggered Benzodiazepine Dosing
- Lorazepam 2-4 mg PO/IV every 1 hour PRN for CIWA-Ar ≥8-10 1, 2
- Reassess CIWA-Ar 1 hour after each dose 2
- Continue symptom-triggered dosing rather than fixed-schedule to prevent drug accumulation 1
Rationale for Lorazepam Selection
- Lorazepam (intermediate-acting) is preferred over long-acting benzodiazepines (diazepam, chlordiazepoxide) in patients with hepatic dysfunction because it has no active metabolites and undergoes glucuronidation rather than oxidative metabolism 1, 2
- Equally efficacious to chlordiazepoxide in reducing withdrawal symptoms 3
- In severe alcoholic liver disease, use cautiously with close monitoring for excessive sedation or hepatic encephalopathy 2
Adjunctive Medications
- Thiamine 100 mg IV/IM daily before any glucose administration to prevent Wernicke encephalopathy 2
- Folic acid 1 mg PO daily 2
- Multivitamin daily 2
- Consider clonidine for autonomic hyperactivity (tachycardia, hypertension) if inadequate response to benzodiazepines alone 4, 5
- Consider haloperidol 2-5 mg PO/IV for agitation/delirium not controlled by benzodiazepines 4
Safety Parameters
- Hold lorazepam if: respiratory rate <10/min, oxygen saturation <90%, or excessive sedation 2
- Maximum duration of benzodiazepine therapy: 10-14 days to avoid abuse potential 1
- In patients with hepatic encephalopathy, use benzodiazepines with extreme caution as they may worsen mental status 2
- Avoid disulfiram and naltrexone in acute liver disease due to hepatotoxicity risk 6
Disposition Planning
- Taper benzodiazepines over 5-8 days once withdrawal symptoms controlled 3
- Do not discharge patients on tapered benzodiazepine therapy - complete detoxification in hospital 4
- Arrange addiction medicine follow-up for relapse prevention pharmacotherapy (acamprosate preferred in liver disease, or baclofen if cirrhosis present) 6, 1
Common Pitfalls to Avoid
- Do not use fixed-dose scheduling - symptom-triggered regimens prevent drug accumulation and reduce total benzodiazepine exposure 1
- Do not use long-acting benzodiazepines in hepatic dysfunction - they accumulate and increase encephalopathy risk 1, 2
- Do not rely solely on CIWA-Ar scores >24 to predict ICU need - sensitivity is only 12% for identifying patients requiring high-intensity care 7
- Do not continue benzodiazepines beyond 10-14 days due to abuse potential in this population 1